<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This article outlines the link between the renin angiotensin <z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system (RAAS) and various forms of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, and also reviews the understanding of the effectiveness of RAAS intervention in this phase of ventricular dysfunction </plain></SENT>
<SENT sid="1" pm="."><plain>The authors focus their discussion predominantly on patients who have had previous <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> or those who have <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> and also briefly discuss the role of RAAS activation and intervention in patients with alcoholic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>